Research progress on screening prostate cancer in the PSA"gray zone"and PI-RADS 3 lesions
10.13263/j.cnki.nja.2025.06.009
- VernacularTitle:MRI影像组学在PSA"灰区"和PI-RADS 3分病变中筛查前列腺癌的研究进展
- Author:
You MA
1
;
Cheng YANG
1
Author Information
1. 安徽医科大学第一附属医院泌尿外科/安徽医科大学泌尿外科研究所/泌尿男科疾病研究与医学转化安徽省重点实验室,安徽 合肥 230022
- Publication Type:Journal Article
- Keywords:
prostate cancer;
radiomics;
prostate specific antigen;
PI-RADS 3 lesions;
magnetic resonance imaging
- From:
National Journal of Andrology
2025;31(6):547-551
- CountryChina
- Language:Chinese
-
Abstract:
Prostate cancer is a common tumor of the male genitourinary system,with its incidence continuously increasing.Early accurate diagnosis is crucial for treatment and prognosis.PSA and MRI are important methods for screening and diagnosis of prostate cancer.However,there is still controversy over whether patients with PSA levels between 4-10 μg/L and PI-RADS score of 3 need to undergo prostate biopsy.Radiomics technology provides a new approach for the early and accurate diagnosis of prostate cancer by min-ing and analyzing medical image information in a high throughput,which helps to reduce unnecessary biopsies.This article reviews the research progress of MRI radiomics in the screening of prostate cancer in the"gray zone"of PSA and PI-RADS score of 3,aiming to improve diagnostic accuracy and provide references for future research in the field of radiomics.
